SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 25.33-1.9%Dec 17 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Olu Emuleomo who started this subject6/24/2002 4:04:39 PM
From: aknahow   of 17367
 
Last day for Bax call. Listen now or not at all! Interesting observation. there was indeed a pause between crohn's and sepsis. BTW I did not find this information on my own. A Xoma shareholder called my attention to it.

""Hi. It has been a while since I posted to the SI board, but I'm still here.

Thanks for the link to the Baxter audio conference call mentioning BPI Neuprex for Crohns and SEPSIS. On some audio
players, including mine, the audio play for this conference starts at the 36 minute mark. On both the regular and
external players, I found the mention at 1:18:25 thru 1:18:30, which is about 42 minutes after the start, as you
posted. You might wish to post a clarification so that more people can find it, especially since today (June 24) was
mentioned on the tape as the last day that the audio replay of the June 10 conference would be available.

I also noticed a slight pause between "Crohns" and "Sepsis".
Perhaps the speaker was not sure whether or not sepsis could be mentioned at this point, but mentioned it anyway. To
my ear, it sounds like a possible slip.

Great find, George! With a little luck, this "news" could have a positive impact in the stock price later this year if and
when it gets formally announced.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext